Acetaminophen

0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Genomics
GenomicsUK - Oxford
1 program
genetic polymorphismN/A1 trial
Active Trials
NCT04964310Recruiting339Est. Dec 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Genomicsgenetic polymorphism

Clinical Trials (1)

Total enrollment: 339 patients across 1 trials

NCT04964310Genomicsgenetic polymorphism

Screening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-control Study

Start: Aug 2020Est. completion: Dec 2026339 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 339 patients
1 companies competing in this space